CWM
TEVA icon

CIBC World Markets’s Teva Pharmaceuticals TEVA Stock Holding History

CIBC World Markets’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-99,000
Closed -$3.18M – 672
2017
Q1 		$3.18M Hold
99,000
– – 0.03% 301
2016
Q4 		$3.59M Hold
99,000
– – 0.04% 237
2016
Q3 		$4.55M Buy
+99,000
New +$5.17M 0.09% 150

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CIBC World Markets's TEVA Position: Q2 2017 in Review

CIBC World Markets sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 99,000 shares — an estimated $3.18M sold.

CIBC World Markets first reported a position in TEVA in Q3 2016 and held it in 3 quarters. The position peaked at $4.55M in Q3 2016. 650 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • CIBC World Markets reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • CIBC World Markets sold 99,000 Teva Pharmaceuticals shares in Q2 2017, an estimated $3.18M.
  • CIBC World Markets first reported a position in Teva Pharmaceuticals in Q3 2016 and held it in 3 quarters.
  • CIBC World Markets's Teva Pharmaceuticals position peaked at $4.55M in Q3 2016.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on CIBC World Markets's 13F filing for Q2 2017, filed 11 Aug 2017.